Meckler Jeffrey A — SEC insider filings

SEC reporting owner CIK 1506916. 26 insider filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-05-18 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Travere Therapeutics, Inc. (TVTX)Director9—6 legs · 68,000 sh · $2,268,43020
Indaptus Therapeutics, Inc. (INDP)Co-Chief Executive Officer, Director178 legs · 72,914 sh · $273,569—24

Insider filings — Meckler Jeffrey A

FiledFormIssuerReported transactionsSource
2026-09-114Travere Therapeutics, Inc. (TVTX)Option exercise (M): 10,000 @ $17.44 · Option exercise (M): 10,000 @ $26.52 · Sale (S): 1,700 @ $65.39 · Sale (S): 1,200 @ $66.15 · Sale (S): 14,000 @ $67.46 · Sale (S): 3,100 @ $68.09 · +2 moreEDGAR
2026-05-214Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-05-064Travere Therapeutics, Inc. (TVTX)Option exercise (M): 8,000 @ $16.33 · Sale (S): 8,000 @ $45 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2026-02-134Indaptus Therapeutics, Inc. (INDP)Disposition to issuer (D): 3,033 (derivative) · Grant/award (A): 3,033 (derivative) · Disposition to issuer (D): 1,519 (derivative) · Grant/award (A): 1,519 (derivative) · Disposition to issuer (D): 12,136 (derivative) · Grant/award (A): 12,136 (derivative)EDGAR
2025-12-294Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 216,617 @ $2.03EDGAR
2025-07-294Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 6,068 @ $8.30 · Grant/award (A): 12,136 (derivative) @ $8.30EDGAR
2025-05-164Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2025-04-114Indaptus Therapeutics, Inc. (INDP)Disposition to issuer (D): 4,750 (derivative) @ $0.04 · Disposition to issuer (D): 3,750 (derivative) @ $0.04 · Disposition to issuer (D): 813 (derivative) @ $0.04 · Disposition to issuer (D): 1,500 (derivative) @ $0.04 · Disposition to issuer (D): 1,563 (derivative) @ $0.04 · Disposition to issuer (D): 1,250 (derivative) @ $0.04EDGAR
2024-11-264Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 42,553 @ $1.18 · Grant/award (A): 42,553 (derivative) @ $1.18EDGAR
2024-10-104Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2024-09-304Travere Therapeutics, Inc. (TVTX)Option exercise (M): 40,000 @ $10.48 · Sale (S): 40,000 @ $14.06 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-08-084Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 84,932 @ $1.82 · Grant/award (A): 84,932 (derivative) @ $1.82EDGAR
2024-05-104Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2024-01-234Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-05-194Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,500 @ $0 · Grant/award (A): 13,500 (derivative) @ $0EDGAR
2023-01-204Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-11-224Indaptus Therapeutics, Inc. (INDP)Purchase (P): 400 @ $1.76 · Purchase (P): 9,600 @ $1.90EDGAR
2022-09-124Indaptus Therapeutics, Inc. (INDP)Purchase (P): 10,308 @ $2.80EDGAR
2022-09-084Indaptus Therapeutics, Inc. (INDP)Purchase (P): 1,060 @ $2.44 · Purchase (P): 8,632 @ $2.57EDGAR
2022-06-074Indaptus Therapeutics, Inc. (INDP)Purchase (P): 19,727 @ $2.63EDGAR
2022-05-124Travere Therapeutics, Inc. (TVTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2022-01-284Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2021-11-194Indaptus Therapeutics, Inc. (INDP)Purchase (P): 11,187 @ $5.82EDGAR
2021-09-164Indaptus Therapeutics, Inc. (INDP)Purchase (P): 12,000 @ $7EDGAR
2021-08-064Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2021-05-184Travere Therapeutics, Inc. (TVTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1506916 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs